Eli Lilly and Company (FRA:LLY)
Germany · Delayed Price · Currency is EUR 650.00
+31.90 (5.16%)
At close: Sep 30, 2025
Eli Lilly and Company Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
€964,878
Profits / Employee
€250,013
Market Cap
583.80B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 327,000 |
| Deutsche Telekom AG | 198,194 |
| Allianz SE | 156,626 |
| Rheinmetall AG | 28,539 |
| Siemens Energy AG | 98,000 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Eli Lilly and Company News
- 1 day ago - Eli Lilly: Strong Buy On Sustained Growth, Expanding Moat, And Pipeline Depth - Seeking Alpha
- 1 day ago - LLY Stock Set For A 20% Breakout? - Forbes
- 2 days ago - Novo, Lilly Weight-Loss Drugs May Help Alzheimer's Patients. What It Means for the Stocks. - Barrons
- 4 days ago - A New Prescription For Pain: Understanding Trump's 100% Pharma Tariff - Seeking Alpha
- 4 days ago - Lilly opens newest Gateway Labs site in San Diego to boost local biotechnology ecosystem - PRNewsWire
- 4 days ago - Eli Lilly, Pfizer Stocks Rise After Trump's 100% Pharma Tariff Threat. Here's Why. - Barrons
- 5 days ago - Lilly's Kisunla (donanemab) receives marketing authorization by European Commission for the treatment of early symptomatic Alzheimer's disease - PRNewsWire
- 5 days ago - US FDA approves Eli Lilly's therapy for metastatic breast cancer - Reuters